Accent Therapeutics

Translating extraordinary science into life-changing therapeutics for patients living with cancer

Business Model
B2B
Last Round
Series CJan 2024
Rounds
3

About

Accent Therapeutics takes a novel view of cancer by leveraging expertise in genomic instability and small-molecule drug discovery. The company looks beyond mutation-specific vulnerabilities to identify and exploit critical cellular dependencies that result from genomic and chromosomal instability observed across multiple cancer types. It develops small-molecule therapeutics designed to inhibit those targets, with programs that have the potential to benefit large patient populations with significant unmet medical need.

Summary

Accent Therapeutics is a Biotech company based in United States. Its most recent funding was a Series C round in Jan 2024. Investors include EcoR1 Capital, Mirae Asset and The Column Group.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CJan 2024

Sign up to see all 3 rounds

Series A through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Accent Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/accent-therapeutics"><img src="https://indexed.vc/api/badge/company/accent-therapeutics" alt="Accent Therapeutics on Indexed.vc" width="260" height="76" /></a>